Long-circulating iron oxides for MR imaging

[1]  Michael G. Aquilia.  Technical Magnetic Resonance Imaging , 1996 .

[2]  R. Weissleder.  Liver MR imaging with iron oxides: toward consensus and clinical practice. , 1994, Radiology.

[3]  R. Weissleder,et al.  Pancreatic receptors: initial feasibility studies with a targeted contrast agent for MR imaging. , 1994, Radiology.

[4]  R. Weissleder,et al.  Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes. , 1994, Biochimica et biophysica acta.

[5]  A. Olukotun,et al.  Phase I clinical evaluation of a new iron oxide MR contrast agent , 1994, Journal of magnetic resonance imaging : JMRI.

[6]  R Weissleder,et al.  MR lymphography: study of a high-efficiency lymphotrophic agent. , 1994, Radiology.

[7]  R. Weissleder,et al.  Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals. , 1994, AJR. American journal of roentgenology.

[8]  H. Bengele,et al.  Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration. , 1994, Magnetic resonance imaging.

[9]  R. Weissleder,et al.  MR Imaging of Slow Axonal Transport in Vivo , 1993, Experimental Neurology.

[10]  R Weissleder,et al.  Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties , 1993, Magnetic resonance in medicine.

[11]  R. Klausner,et al.  Regulating the fate of mRNA: The control of cellular iron metabolism , 1993, Cell.

[12]  I. Papisov,et al.  Polymer-inorganic composites produced by matrix condensation of titanium(IV) hydroxide in the presence of polyethylene glycol , 1993 .

[13]  T J Brady,et al.  Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. , 1992, Radiology.

[14]  J. Wittenberg,et al.  MR antibody Imaging: Antlmyosln labelled with monocrystalllne Iron oxide allows detection of myocardial Infarct , 1991 .

[15]  A. Fischman,et al.  Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. , 1991, Radiology.

[16]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. , 1990, Radiology.

[17]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[18]  T. Kent,et al.  Assessment of a superparamagnetic iron oxide (ami‐25) as a brain contrast agent , 1990, Magnetic resonance in medicine.

[19]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[20]  J C Gore,et al.  Regional differences in rat brain displayed by fast MRI with superparamagnetic contrast agents. , 1988, Magnetic resonance imaging.

[21]  M. de Cuyper,et al.  Magnetoliposomes , 1988, European Biophysics Journal.

[22]  V. Torchilin,et al.  Magnetic drug targeting. II. targeted drug transport by magnetic microp articles: factors influencing therapeutic effect , 1987 .

[23]  V. Torchilin,et al.  Magnetic drug targeting. I. in vivo kinetics of radiolabelled magnetic drug carriers , 1987 .

[24]  A. Ericsson,et al.  Relaxation Enhancement of the Dog Liver and Spleen by Biodegradable Superparamagnetic Particles in Proton Magnetic Resonance Imaging , 1987, Acta radiologica.

[25]  R R Edelman,et al.  Magnetite albumin microspheres: a new MR contrast material. , 1987, AJR. American journal of roentgenology.

[26]  T J Brady,et al.  Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. , 1987, Radiology.

[27]  P. Lauterbur,et al.  Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen , 1986, Magnetic resonance in medicine.

[28]  P F Renshaw,et al.  Ferromagnetic contrast agents: A new approach , 1986, Magnetic resonance in medicine.

[29]  L. Salford,et al.  Ferromagnetic particles as contrast agent in T2 NMR imaging , 1986 .

[30]  B. Bacon,et al.  Hemochromatosis: How much iron is too much? , 1986, Hepatology.

[31]  H. Kressel.  Magnetic resonance annual , 1985 .

[32]  [5] Biophysical drug targeting: Magnetically responsive albumin microspheres , 1985 .

[33]  M. Weir,et al.  Haemosiderin and tissue damage , 1984, Cell biochemistry and function.

[34]  M. Homma,et al.  Magnetic microcapsules for targeted delivery of anticancer drugs. , 1984, Applied biochemistry and biotechnology.

[35]  K. Widder,et al.  Magnetic Microspheres: A Model System for Site Specific Drug Delivery in Vivo 1 , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[36]  G. Miskolczy,et al.  Some applications of ferrofluid magnetic colloids , 1970 .